Instrument NameAbbvie IncInstrument Symbol(ABBV-N)

Instrument ExchangeNYSE

These three companies have track records that should please investors.

The pharmaceutical company isn't just a quality healthcare holding. It's a compelling income investment as well.

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks to fewer side effects for patients. Even a partial replacement for chemotherapy could make it a $140 billion market - and one company is set to dominate this field.

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

All 3 companies pay growing dividends.

These pharmaceutical companies are top-notch dividend growth stocks for the future.

These are low-risk stocks with high yields.

QULIPTA is now the first and only oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) approved to prevent migraine across all frequencies,...

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.13%. US stock indexes on Monday settled moderately higher, with the S&P 500 and Nasdaq...

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. US stock indexes this morning are moderately higher, with the S&P 500 and...

A little patience with the drugmaker should pay off.

One thing is for sure: Dividend seekers can't go wrong with either.

You'll get dividends and more with these great stocks.

Investors are struggling to see past the end of Humira's dominance.

ABBV earnings call for the period ending March 31, 2024.

June S&P 500 E-Mini futures (ESM24) are up +0.63%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.86% this morning as upbeat quarterly results from tech titans Alphabet and Microsoft boosted sentiment, while investors geared up for the release of the Fed’s preferred inflation gauge.

All three of these stocks look intriguing.

June S&P 500 E-Mini futures (ESM24) are up +0.48%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.58% this morning as market participants looked ahead to earnings reports from some of the biggest tech heavyweights as well as the release of the Fed’s favorite inflation gauge later in the week.

The JPMorgan Equity Premium Income ETF produces a lucrative monthly passive income stream.

Monday U.S. Featured Earnings Verizon Communications Inc. (NYSE:VZ) (Q1) EPS of $1.12, ...

Investors can consider adding defensive stocks, such as AbbVie and Verizon, to their equity portfolios in 2024 to help shield against heightened stock market volatility.

Everything is going according to plan, and more growth is on the way.

Income-seeking investors can look forward to steady payout raises from these pharma stocks.

Income investors will find a lot to like about these stocks.

June S&P 500 E-Mini futures (ESM24) are trending up +0.27% this morning as investors looked ahead to the release of crucial U.S. nonfarm payrolls data to gauge the timing of the Federal Reserve’s interest-rate cuts.